Literature DB >> 311816

Continuously proliferating allospecific T cells. I. Specificity of cooperation with allogeneic B cells in the humoral antibody response to sheep erythrocytes.

J D Waterfield, G Dennert, S L Swain, R W Dutton.   

Abstract

Allospecific mouse T cells, positively selected in one-way mixed lymphocyte culture were maintained for 3 yr in tissue culture by sequential restimulation. Such proliferating T cells were tested for their ability to induce a positive allogeneic effect: activating B cells in an in vitro primary humoral response to sheep erythrocytes. It was found that such T lymphocytes could function as helper cells. Helper activity was shown to be specific in that the B cells activated had to share major histocompatibility complex (H-2) antigens with the strain used for selection of the cell line. Intra H-2 mapping showed that antigens coded in the IAk subregion played an important role in the induction of the positive allogeneic effect. Supernatant factors could substitute for the allogeneic T cells in activation of the in vitro humoral response. However, such supernates exhibited no strain specificity. Therefore, the specificity seen in the positive allogeneic effect is presumably a consequence of the alloantigenic recognition receptors intrinsic to the T cells, and not to any biologically restricting properties of the allogeneic effect factor itself.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 311816      PMCID: PMC2184850          DOI: 10.1084/jem.149.4.808

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  Positive and negative allogeneic effects mediated by MLR-primed lymphocytes: quantitation by limiting dilution analysis.

Authors:  R B Corley; B Kindred; I Lefkovits
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

2.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

3.  Alloantigen-induced T helper activity. I. Minimal genetic differences necessary to induce a positive allogeneic effect.

Authors:  P R Panfili; R W Dutton
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Negative allogeneic effects in vitro. I. Allogeneic T cells markedly suppress the secondary antibody-forming cell response.

Authors:  S L Swain; R W Dutton
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

5.  Brain-associated theta antigen: reactivity of rabbit anti-mouse brain with mouse lymphoid cells.

Authors:  E S Golub
Journal:  Cell Immunol       Date:  1971-08       Impact factor: 4.868

6.  The allogeneic effect: bystander effect in the primary immune response in vitro.

Authors:  J Kettman; H Skarvall
Journal:  Eur J Immunol       Date:  1974-10       Impact factor: 5.532

7.  Failure of T cells specific for strong histocompatibility antigens to cooperate with B cells for a humoral response.

Authors:  G Dennert; M De Rose; R S Allen
Journal:  Eur J Immunol       Date:  1977-07       Impact factor: 5.532

8.  Continuously proliferating allospecific T cells, lifespan and antigen receptors.

Authors:  G Dennert; W Raschke
Journal:  Eur J Immunol       Date:  1977-06       Impact factor: 5.532

9.  In vitro analysis of allogeneic lymphocyte interaction. II. I-region control of the activity of a B-cell-derived H-2-restricted allogeneic effect factor and its receptor during B-cell activation.

Authors:  T L Delovitch; J Biggin; F Y Fung
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  Regulation of the immune response. II. Qualitative and quantitative differences between thymus- and bone marrow-derived lymphocytes in the recognition of antigen.

Authors:  M Hoffmann; J W Kappler
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

View more
  11 in total

1.  Fine specificity of a proliferating T-cell clone activated by a conformational determinant of the I-Ek molecule.

Authors:  A Pierres; M Pierres
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

2.  Helper T cell activity demonstrated by thymic nurse T cells (TNC-T).

Authors:  D D Vakharia; N A Mitchison
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

3.  Lymphokine-induced suppressor B cells.

Authors:  K M Gilbert; M K Hoffmann
Journal:  Immunology       Date:  1982-07       Impact factor: 7.397

4.  Allospecific T-cell lines with functional activities.

Authors:  A A Czitrom; N A Mitchison
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

5.  T-cell responses to minor histocompatibility antigens.

Authors:  P K Lai; J D Waterfield; N R Gascoigne; C E Sharrock; N A Mitchison
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

6.  T cells may express multiple activities: specific allohelp, cytolysis, and delayed-type hypersensitivity are expressed by a cloned T-cell line.

Authors:  G Dennert; S Weiss; J F Warner
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

7.  Culture supernatants of a stimulated T-cell line have helper activity that acts synergistically with interleukin 2 in the response of B cells to antigen.

Authors:  S L Swain; G Dennert; J F Warner; R W Dutton
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

8.  Specific T helper cells that activate B cells polyclonally. In vitro enrichment and cooperative function.

Authors:  A A Augustin; A Coutinho
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

9.  T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells.

Authors:  P C Isakson; E Puré; E S Vitetta; P H Krammer
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

10.  Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype.

Authors:  G J Prud'Homme; C L Park; T M Fieser; R Kofler; F J Dixon; A N Theofilopoulos
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.